Class II

Drug Recall: bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose Syringe, Fagron Sterile Services, 8710 E 34th St N. Wichita, KS 67226

Fagron Compounding Services · August 29, 2025

Reason for Recall

Lack of Assurance of Sterility

Distribution

USA nationwide.

States Affected

NATIONWIDE

Quantity Affected

109,320 syringes

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0646-2025

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.